Contract Development Services

Developing the Best Formulation Partnership

August 02, 2021

Collaborative partnerships can foster success in formulation development projects.

Integrated Approach Facilitates Inhalation Drug Development

August 01, 2021

The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.

Pharma Services Sector Poised for Continued Growth and Consolidation

August 01, 2021

The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.

Lonza and CellPoint Collaborate to Develop T-cell Based Therapies

June 24, 2021

The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.

SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate

June 24, 2021

The companies have entered into an agreement to develop processes for a novel immunotherapy protein.

Vectura Signs Agreement with Incannex to Advance TBI Treatment

June 22, 2021

Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.

Outlining the Key Steps to Method Development

June 22, 2021

Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.

Developing a Method for Success through Partnerships

June 02, 2021

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Expediting IND Submission

March 18, 2021

An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.